Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Raymond March
48 POSTS
0 COMMENTS
Raymond J. March
is a Research Fellow at the Independent Institute and Assistant Professor of Economics at North Dakota State University.
All Blog Posts
|
Full bio and publications
Deregulation Is the Only Cure for High Drug Prices
Raymond March
-
January 3, 2019
0
FDA Vaping Regulations Will Do More Harm than Good
Raymond March
-
November 30, 2018
0
To Help the Terminally Ill, the FDA Must Deregulate
Raymond March
-
November 14, 2018
0
When Healthy Policy Neglects Economic Principles, Patients Suffer
Raymond March
-
October 13, 2018
0
FDA Still Hooked on Meddling in Nicotine Markets
Raymond March
-
October 8, 2018
0
FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple...
Raymond March
-
September 26, 2018
0
Let Competition, Not the FDA, Resolve the EpiPen Shortage
Raymond March
-
September 12, 2018
0
Government vs. Private Efforts to Promote Breastfeeding: My Response to a...
Raymond March
-
September 2, 2018
0
FDA Considers Regulating E-cigarette Juices
Raymond March
-
September 1, 2018
0
FDA Approves Medical App for Contraception
Raymond March
-
August 22, 2018
0
1
2
3
4
5
Page 3 of 5
Edit with Live CSS
